Clinical trial
Second Primary Cancers in Patients With Castration Resistant Prostate Cancer (BOCARP)
NCT02702908 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Second Primary Cancers in Patients With Castration Resistant Prostate Cancer (BOCARP)
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 15, 2016
- Completion date
- October 20, 2017
- Enrollment
- 6,442 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.